Cue Biopharma, Inc. · NASDAQ:CUE
Meluzio Michael Vincent sold 1,144 Cue Biopharma, Inc. shares (Form 4)
Traded Oct 12, 2026 · Filed Oct 14, 2026
On Oct 12, 2026, Meluzio Michael Vincent (VP, Prin. Accounting Officer) sold 1,144 Cue Biopharma, Inc. shares at US$28.05 for US$32,089, leaving 47,817 shares. Filed Oct 14, 2026 (Form 4).
- Sold
- 1,144 shares
- Price
- US$28.05
- Value
- US$32,089
- Holding after
- 47,817 shares
- Trading plan
- No
- Role
- VP, Prin. Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | Common Stock | Sale | 1,144 | US$28.05 | 47,817 | Direct |
Source
Download original · View original at SEC
Related
- Cue Biopharma, Inc.
- Meluzio Michael Vincent
- Cue Biopharma, Inc. shareholders
- Form 4 · Meluzio Michael Vincent · Aug 17, 2026
- Form 4 · Meluzio Michael Vincent · Jul 10, 2026
- Form 4 · Ray Sumita · Oct 14, 2026
- Form 4 · Lin Shao-Lee · Oct 14, 2026
- Schedule 13G/A · Mark E. Strome · Oct 8, 2026
- Form 4/A · Sarraf Pasha · Aug 28, 2026
- Form 4/A · Garzone Pamela · Aug 28, 2026